Clinical Trial Update: Study of DU-176b Aged 80 Years or Older [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for DU-176b in adults 80 years or older with atrial fibrillation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2020-11-19